Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial-Reference-Cited by-同舟云学术

Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial

Published:2019-08-01 Issue:4 Volume:81 Page:463-472
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Johnson Margaret,Kumar Princy,Molina Jean-Michel,Rizzardini Giuliano,Cahn Pedro,Bickel Markus,Mallolas Josep,Zhou Yan,Morais Cristiana,Kumar Sushma,Sklar Peter,Hanna George J.,Hwang Carey,Greaves Wayne,

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference21 articles.

1. HIV drug resistance—an emerging threat to epidemic control;Beyrer;N Engl J Med.,2017

2. Durable viral suppression and transmission risk potential among persons with diagnosed HIV infection: United States, 2012–2013;Crepaz;Clin Infect Dis.,2016

3. Increased antiretroviral therapy prescription and HIV viral suppression among persons receiving clinical care for HIV infection;Bradley;AIDS.,2016

4. Changes in viral suppression status among US HIV-infected patients receiving care;Crepaz;AIDS.,2017

5. Compliance with clinical guidelines and adherence to antiretro-viral therapy among patients living with HIV;Tandon;Curr Med Res Opin.,2018

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Weight change with antiretroviral switch from integrase inhibitor or tenofovir alafenamide-based to Doravirine-Based regimens in people with HIV;HIV RES CLIN PRACT;2024

2. Real-world effectiveness and tolerability of switching to doravirine-based antiretroviral therapy in people with HIV: a nationwide, matched, prospective cohort study;The Lancet HIV;2024-09

3. Long-term effectiveness, safety, and tolerability of doravirine in antiretroviral-experienced people with HIV in real life;Microbiology Spectrum;2024-08-06

4. DORAVIR: a French national survey of people with HIV-1 treated with an antiretroviral regimen including doravirine;Journal of Antimicrobial Chemotherapy;2024-06-17

5. Clinical considerations when switching antiretroviral therapy;Expert Review of Clinical Pharmacology;2024-06-17